Frequent involvement of Ras-signaling pathways in both polypoid-type and flat-type early-stage colorectal cancers

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 2, 2006, Pages 235-242

  Noda, H ^a,b   Kato, Y ^a   Yoshikawa, H ^a   Arai, M ^a   Togashi, K ^b   Nagai, H ^b   Konishi, F ^b   Miki, Yoshio ^a,c  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adenoma carcinoma sequence; BRAF; Early colorectal cancer; K ras; RASSF1A

Indexed keywords

B RAF KINASE; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ELECTROPHORESIS; EPIGENETICS; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; POLYPLOIDY; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS B-RAF; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33746355981     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vogelstein B., Fearson E.R., Hamilton S.R., et al.: Genetic alterations during colorectal-tumor development. N. Eng. J. Med. 319:525-532, 1988.
2. Morson B.C.: Precancerous and early malignant lesions of the large intestine. Br. J. Surg. 55:725-731, 1968.
3. Powell S.M., Zilz N., Beazer-Barkley Y., et al.: APC mutations occur early during colorectal tumoriogenesis. Nature. (Lond) 359:235-237, 1992.
4. Forrester K., Almoguera C., Hank K., Grizzle W.E., Perucho M.: Detection of high incidence of K-ras oncogenes during human colon tumoriogenesis. Nature. (Lond) 327:298-303, 1987.
5. Bos J.L., Fearon E.R., Hamilton S.R., et al.: Prevalence of ras gene mutations in human colorectal cancers. Nature. (Lond) 327:293-297, 1987.
6. Thiagaliangam S., Lengauer C., Leach F.S., et al.: Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancer. Nature. Gene. 13:343-346, 1996.
7. Kikuchi-Yanoshita R., Konishi M., Fukunari H., Tanaka K., Miyaki M.: Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer. Res. 52:3801-3803, 1992.
8. Baker S.J., Fearson E.R., Nigro J.M., et al.: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. (Wash DC) 244:217-221, 1989.
9. Ohue M., Tomita N., Monden T., et al.: A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer. Res. 54:4798-4804, 1994.
10. Greenblatt M.S., Bennett W.P., Hollestein M., Harris C.C.: Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer. Res. 54:4855-4878, 1994.
11. Davies H., Bignell G.R., Cox C., et al.: Mutations of the BRAF gene in human cancer. Nature. 417:949-954, 2002.
12. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J.: Ras uses the novel tumor suppressor RASSF1A as an effector to mediate apoptosis. J. Biol. Chem. 275:35669-35672, 2000.
13. Dammann R, Li C, Yoon J.H., Chin P.L., Bates S., Pfeifer G.P.: Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nature. Genetics. 25:315-319, 2000.
14. Dammann R., Takahashi T., Pfeifer G.P.: The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small lung cell carcinomas. Oncogene. 20:3563-3567, 2001.
15. Engeland M.V., Roemen G.M.J.M., Brink M., et al.: K-ras mutation and RASSF1A promoter methylation in colorectal cancer. Oncogene. 21:3792-3795, 2002.
16. Muto T., Nagawa H., Watanabe T., Masaki T., Sawada T.: Colorectal carcinogenesis: historical review. Dis. Colon. Rectum. 40 (suppl): S80-S85, 1997.
17. Minamoto T., Sawaguchi K., Ohta T., Itoh T., Mai M.: Superficial-type adenoma and adenocarcinoma of the colon and rectum: a comparative morphological study. Gastroenterology. 106:1436-1443, 1994.
18. Minamoto T., Sawaguchi K., Mai M., Yamashita N., Sugimura T., Esumi H.: Infrequent K-rai activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer. Res. 54:2841-2844, 1994.
19. Kojima M., Konishi F., Tsukamoto T., Yamashita K., Kanazawa K.: K-ras point mutation in different types of colorectal carcinomas in early stages. Dis. Colon. Rectum. 40:161-167, 1997.
20. Umetani N., Sasaki S., Masaki T., Watanabe T., Matsuda K., Muto T.: Involvement of APC and K-ras mutation in non-polypoid colorectal tumoriogenesis. Br. J. Cancer. 82:9-15, 2000.
21. Rubio C.A., Kumagai J., Kanamori T., Yanagisawa A., Nakamura K., Kato Y.: Flat adenomas and flat adenocarcinomas of the colorectal mucosa in Japanese and Swedish patient: comparative histologic study. Dis. Colon. Rectum. 38:1075-1079, 1995.
22. Schlemper R.J., Itabashi M., Kato Y., et al.: Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer. 82:60-69, 1998.
23. Okamoto T., Konishi F., Kojima M., Senba S., Kanazawa K., Tsukamoto T.: Significance of microsatellite instability in different types of early-stage nonfamilial colorectal carcinomas. Dis. Colon. Rectum. 41:1385-1391, 1998.
24. Ozawa A., Konishi F., Fukayama M., Kanazawa K.: Apoptosis and its regulation in flat-type early colorectal carcinoma. Comparison with that in polypoid-type early colorectal carcinoma. Dis. Colon. Rectum. 43(Suppl):S23-S28, 2000.
25. Goeltz S.E., Hamilton S.R., Vogelstein B.: Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun. 130:118-126, 1985.
26. Rajagopalan H., Bardelli A., Lengauer C., Kintzler K.W., Vogelstein B., Velculescu V.E.: RAF/RAS oncogenes and mismatch-repair status. Nature. 418:934, 2002.
27. Yuen ST., Davies H., Chan T.L., et al.: Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer. Res. 62:6451-6455, 2002.
28. Wang L., Cunningham J.M., Winters J.L., et al.: BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer. Res. 63:5209-5212, 2003.
29. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B.: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93:821-826, 1996.
30. Engeland M.V., Weijenberg M.P., Roemen G.M.J.M., et al.: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer. Res. 63:3133-3137, 2003.
31. Finlay C.A., Hinds P.W., Tan T.H., Eliyasu D., Oren M., Levine A.J.: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8:531-539, 1998.
32. Cunningham J., Lust J.A., Schaid D.J., et al.: Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer. Res. 52:1974-1980, 1992.
33. Oliveira C., Pinto M., Duval A., et al.: BRAF mutations characterize colon but gastric cancer with mismatch repair deficiency. Oncogene. 22:9192-9296, 2003.
34. Koinuma K., Shitoh K., Miyakura Y., et al.: Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int. J. Cancer. 108:237-242, 2004.